PET-CT IMAGING
	A Stanford image combining positron emission tomography (PET) and computed tomography (CT) scans of a patient with lung cancer

Researchers are also working on strategies to merge anatomical (CT) and molecular (PET, etc.) imaging data to achieve a more refined, 3-D view of a tumor’s location and activity.

Preliminary findings show that in some instances, placing biochemical patient data within a detailed, 3-D representation of the patient’s anatomy offers significant advantages over standard 2-D PET/CT imaging during pre-procedural or pre-surgical planning. This work is carried out in collaboration with the 3D Medical Imaging Lab and the Molecular Imaging Program at Stanford (MIPS).

Scientific Goals

• Developing practical pre-clinical and clinical instrumentation that will have enhanced sensitivity/resolution for improved cancer imaging
• Development of intra-operative imaging strategies for cancer treatment
• Development of novel methods to marry anatomical and molecular imaging

Program Researchers

Christopher Beaulieu, MD, PhD Kim Butts, PhD Bruce Daniel, MD Gary Glazer, MD Gary Glover, PhD Michael Goris, MD, PhD Robert Herfkens, MD Debra Ikeda, MD Butrus Khuri-Yakub, PhD Gordon Kino, PhD Craig Levin, PhD Michael Moseley, PhD

Sandy Napel, PhD Dwight Nishimura, PhD John Pauly, PhD Norbert Pelc, ScD Andrew Quon, MD Geoffrey Rubin, MD Olav Solgaard, PhD F. Graham Sommer, MD Mark Schnitzer, PhD Robert Sinclair, PhD Daniel Spielman, PhD